z-logo
Premium
Nodal factors predictive of recurrence and survival in patients with oral cavity squamous cell carcinoma
Author(s) -
Son H.J.,
Roh J.L.,
Cho K.J.,
Choi S.H.,
Nam S.Y.,
Kim S.Y.
Publication year - 2018
Publication title -
clinical otolaryngology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.914
H-Index - 68
eISSN - 1749-4486
pISSN - 1749-4478
DOI - 10.1111/coa.12995
Subject(s) - medicine , hazard ratio , multivariate analysis , proportional hazards model , oncology , lymph node , nodal , survival analysis , univariate analysis , metastasis , basal cell , gastroenterology , cancer , confidence interval
Objectives Lymph node ( LN ) metastasis of oral cavity squamous cell carcinoma ( OSCC ) is associated with survival outcomes. However, the relationship between different metastatic nodal factors and treatment outcomes requires further elucidation. This study examined nodal factors predictive of recurrence and survival in patients with OSCC . Methods This prospective observational study included 157 patients with OSCC who underwent surgery between 2010 and 2015. Clinicopathological and follow‐up information were recorded. Univariate and multivariate Cox proportional hazard models were performed to identify factors associated with recurrence‐free survival, disease‐specific survival and overall survival. Results Sixty‐five of 157 patients (41.4%) had neck metastasis. During a median follow‐up of 46 months, any recurrences and all deaths occurred in 43 (27.4%) and 43 (27.4%) of cases, respectively. All nodal factors ( LN classification, size, number and ratio) and extra‐nodal extension were significantly associated with all survival outcomes ( P  <   .001). Multivariate analyses indicated that a tumour size >2 cm and LN ratio were independently associated with all survival ( P  <   .05). Patients with LN ratio >0.05 had sixfold higher recurrence and mortality rates than other patients ( P  <   .001). Conclusion Lymph node ratio is an independent and predictive determinant of post‐treatment recurrence and survival.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here